Safety and efficacy of the direct endonasal transsphenoidal approach for challenging sellar tumors.

Nader Sanai, Alfredo Quiñones-Hinojosa, Jared Narvid, Sandeep Kunwar

Research output: Contribution to journalArticle

Abstract

INTRODUCTION: The direct endonasal approach to pituitary microadenomas is relatively atraumatic, rapid, and carries a lower complication rate than the sublabial approach. Large macroadenomas (3-4 cm) can still be addressed with this simple, unmodified direct endonasal approach. We present our experience with this unique and challenging patient population. METHODS: About 64 consecutive patients with large (3-4 cm) pituitary adenomas and craniopharyngiomas were treated by the senior author (SK) using the direct endonasal approach from May 2001 to July 2004. The hospital course, endocrinological function, radiographic imaging, and outpatient follow-up were retrospectively reviewed for each patient. RESULTS: The mean volume of these lesions was 31.5 cm(3) (range, 10.3-168 cm(3)). Tumor pathologies included 2 craniopharyngiomas, 16 functional, and 46 nonfunctional pituitary adenomas. Suprasellar extension of tumor was evident in all patients and 10 had cavernous sinus invasion. Gross total resection was achieved in 30 patients, near-gross total in 6 patients, and subtotal resection in 26 patients. Eight patients (12.5%) demonstrated postoperative complications, with diabetes insipidus for less than 1 year (n = 4) being the most common. There was no incidence of CSF leak, new panhypopituitarism, or worsened vision. Five patients (7.8%) had tumor residual requiring radiation therapy. Additionally, after a mean clinical follow-up of 24.5 months, 4 patients (6.3%) demonstrated recurrent disease. CONCLUSIONS: Direct endonasal transsphenoidal surgery enables safe and effective resection of large sellar masses while maintaining a favorable morbidity profile.

Original languageEnglish (US)
Pages (from-to)317-325
Number of pages9
JournalJournal of Neuro-Oncology
Volume87
Issue number3
DOIs
StatePublished - May 2008
Externally publishedYes

Fingerprint

Safety
Neoplasms
Craniopharyngioma
Pituitary Neoplasms
Cavernous Sinus
Diabetes Insipidus
Residual Neoplasm
Outpatients
Radiotherapy
Pathology
Morbidity
Incidence
Population

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neuroscience(all)

Cite this

Safety and efficacy of the direct endonasal transsphenoidal approach for challenging sellar tumors. / Sanai, Nader; Quiñones-Hinojosa, Alfredo; Narvid, Jared; Kunwar, Sandeep.

In: Journal of Neuro-Oncology, Vol. 87, No. 3, 05.2008, p. 317-325.

Research output: Contribution to journalArticle

Sanai, Nader ; Quiñones-Hinojosa, Alfredo ; Narvid, Jared ; Kunwar, Sandeep. / Safety and efficacy of the direct endonasal transsphenoidal approach for challenging sellar tumors. In: Journal of Neuro-Oncology. 2008 ; Vol. 87, No. 3. pp. 317-325.
@article{694ce36f4f874c33bee626298e0d765c,
title = "Safety and efficacy of the direct endonasal transsphenoidal approach for challenging sellar tumors.",
abstract = "INTRODUCTION: The direct endonasal approach to pituitary microadenomas is relatively atraumatic, rapid, and carries a lower complication rate than the sublabial approach. Large macroadenomas (3-4 cm) can still be addressed with this simple, unmodified direct endonasal approach. We present our experience with this unique and challenging patient population. METHODS: About 64 consecutive patients with large (3-4 cm) pituitary adenomas and craniopharyngiomas were treated by the senior author (SK) using the direct endonasal approach from May 2001 to July 2004. The hospital course, endocrinological function, radiographic imaging, and outpatient follow-up were retrospectively reviewed for each patient. RESULTS: The mean volume of these lesions was 31.5 cm(3) (range, 10.3-168 cm(3)). Tumor pathologies included 2 craniopharyngiomas, 16 functional, and 46 nonfunctional pituitary adenomas. Suprasellar extension of tumor was evident in all patients and 10 had cavernous sinus invasion. Gross total resection was achieved in 30 patients, near-gross total in 6 patients, and subtotal resection in 26 patients. Eight patients (12.5{\%}) demonstrated postoperative complications, with diabetes insipidus for less than 1 year (n = 4) being the most common. There was no incidence of CSF leak, new panhypopituitarism, or worsened vision. Five patients (7.8{\%}) had tumor residual requiring radiation therapy. Additionally, after a mean clinical follow-up of 24.5 months, 4 patients (6.3{\%}) demonstrated recurrent disease. CONCLUSIONS: Direct endonasal transsphenoidal surgery enables safe and effective resection of large sellar masses while maintaining a favorable morbidity profile.",
author = "Nader Sanai and Alfredo Qui{\~n}ones-Hinojosa and Jared Narvid and Sandeep Kunwar",
year = "2008",
month = "5",
doi = "10.1007/s11060-007-9512-2",
language = "English (US)",
volume = "87",
pages = "317--325",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "3",

}

TY - JOUR

T1 - Safety and efficacy of the direct endonasal transsphenoidal approach for challenging sellar tumors.

AU - Sanai, Nader

AU - Quiñones-Hinojosa, Alfredo

AU - Narvid, Jared

AU - Kunwar, Sandeep

PY - 2008/5

Y1 - 2008/5

N2 - INTRODUCTION: The direct endonasal approach to pituitary microadenomas is relatively atraumatic, rapid, and carries a lower complication rate than the sublabial approach. Large macroadenomas (3-4 cm) can still be addressed with this simple, unmodified direct endonasal approach. We present our experience with this unique and challenging patient population. METHODS: About 64 consecutive patients with large (3-4 cm) pituitary adenomas and craniopharyngiomas were treated by the senior author (SK) using the direct endonasal approach from May 2001 to July 2004. The hospital course, endocrinological function, radiographic imaging, and outpatient follow-up were retrospectively reviewed for each patient. RESULTS: The mean volume of these lesions was 31.5 cm(3) (range, 10.3-168 cm(3)). Tumor pathologies included 2 craniopharyngiomas, 16 functional, and 46 nonfunctional pituitary adenomas. Suprasellar extension of tumor was evident in all patients and 10 had cavernous sinus invasion. Gross total resection was achieved in 30 patients, near-gross total in 6 patients, and subtotal resection in 26 patients. Eight patients (12.5%) demonstrated postoperative complications, with diabetes insipidus for less than 1 year (n = 4) being the most common. There was no incidence of CSF leak, new panhypopituitarism, or worsened vision. Five patients (7.8%) had tumor residual requiring radiation therapy. Additionally, after a mean clinical follow-up of 24.5 months, 4 patients (6.3%) demonstrated recurrent disease. CONCLUSIONS: Direct endonasal transsphenoidal surgery enables safe and effective resection of large sellar masses while maintaining a favorable morbidity profile.

AB - INTRODUCTION: The direct endonasal approach to pituitary microadenomas is relatively atraumatic, rapid, and carries a lower complication rate than the sublabial approach. Large macroadenomas (3-4 cm) can still be addressed with this simple, unmodified direct endonasal approach. We present our experience with this unique and challenging patient population. METHODS: About 64 consecutive patients with large (3-4 cm) pituitary adenomas and craniopharyngiomas were treated by the senior author (SK) using the direct endonasal approach from May 2001 to July 2004. The hospital course, endocrinological function, radiographic imaging, and outpatient follow-up were retrospectively reviewed for each patient. RESULTS: The mean volume of these lesions was 31.5 cm(3) (range, 10.3-168 cm(3)). Tumor pathologies included 2 craniopharyngiomas, 16 functional, and 46 nonfunctional pituitary adenomas. Suprasellar extension of tumor was evident in all patients and 10 had cavernous sinus invasion. Gross total resection was achieved in 30 patients, near-gross total in 6 patients, and subtotal resection in 26 patients. Eight patients (12.5%) demonstrated postoperative complications, with diabetes insipidus for less than 1 year (n = 4) being the most common. There was no incidence of CSF leak, new panhypopituitarism, or worsened vision. Five patients (7.8%) had tumor residual requiring radiation therapy. Additionally, after a mean clinical follow-up of 24.5 months, 4 patients (6.3%) demonstrated recurrent disease. CONCLUSIONS: Direct endonasal transsphenoidal surgery enables safe and effective resection of large sellar masses while maintaining a favorable morbidity profile.

UR - http://www.scopus.com/inward/record.url?scp=48049100411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48049100411&partnerID=8YFLogxK

U2 - 10.1007/s11060-007-9512-2

DO - 10.1007/s11060-007-9512-2

M3 - Article

C2 - 18094936

AN - SCOPUS:48049100411

VL - 87

SP - 317

EP - 325

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 3

ER -